2021
DOI: 10.1080/14779072.2021.1905521
|View full text |Cite
|
Sign up to set email alerts
|

Current challenges and prevention strategies for chronic total occlusion (CTO) complications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6
1

Relationship

2
5

Authors

Journals

citations
Cited by 10 publications
(6 citation statements)
references
References 42 publications
0
6
0
Order By: Relevance
“…12 CTO PCI carries increased risk of complications compared with non-CTO PCI due to complex coronary anatomy (calcification, tortuosity, multivessel disease), difficulties with CTO crossing and comorbidities (left ventricular disfunction, particularly in the donor vessel is being instrumented during retrograde procedures). 1,[13][14][15] How can we identify patients who are more likely to need MCS? We recently developed risk scores for estimating the risk of periprocedural in-hospital major adverse cardiovascular events (MACE), mortality, pericardiocentesis, and acute myocardial infarction (MI) in patients undergoing CTO PCI 11 , but there are currently no risk scores for assessing the need for urgent MCS in CTO PCI.…”
Section: Discussionmentioning
confidence: 99%
“…12 CTO PCI carries increased risk of complications compared with non-CTO PCI due to complex coronary anatomy (calcification, tortuosity, multivessel disease), difficulties with CTO crossing and comorbidities (left ventricular disfunction, particularly in the donor vessel is being instrumented during retrograde procedures). 1,[13][14][15] How can we identify patients who are more likely to need MCS? We recently developed risk scores for estimating the risk of periprocedural in-hospital major adverse cardiovascular events (MACE), mortality, pericardiocentesis, and acute myocardial infarction (MI) in patients undergoing CTO PCI 11 , but there are currently no risk scores for assessing the need for urgent MCS in CTO PCI.…”
Section: Discussionmentioning
confidence: 99%
“…A detailed description of the technical aspects of management of specific CTO PCI complications has been well described elsewhere (51). Many experienced CTO centers presently achieve high success rates (85%-90%) with low (2%-3%) risks of major periprocedural complications (52). By comparison, technical success rates >95% and complication rates <2% have been reported for non-complex non-CTO PCI-compared to success rates <60% (and >6% incidence of emergent CABG) at the dawn of PCI in the 1980s (53,54).…”
Section: Complications: Prevention Recognition and Managementmentioning
confidence: 99%
“…Identifying patients who are more likely to have procedural complications is essential to stratify the cumulative risk. Several clinical, angiographic, and technical characteristics are related to a greater risk of periprocedural complication of CTO-PCI: elderly, chronic kidney disease (CKD), retrograde and anterograde dissection/re-entry approach, and use of rotational atherectomy, which are associated with a higher risk of coronary perforations [58]. In this context, the PROGRESS-CTO complications score has been developed to predict the risk related to a procedure of CTO recanalization.…”
Section: Cto Complicationsmentioning
confidence: 99%
“…Donor vessel injury is another serious complication occurring during CTO-PCI because it is associated with severe ischemia and hemodynamic decompensation, requiring high doses of vasopressors and/or mechanical hemodynamic support. It can be induced by catheter management, especially in long retrograde procedures [67], or it can be associated with coronary spasm [58]. Donor vessel thrombosis is principally associated with long CTO PCIs, blood stasis, or suboptimal activated clotting time (ACT) [67].…”
Section: Donor Vessel Injurymentioning
confidence: 99%